Ganesan, Murali
- University of Nebraska Medical Center · Internal Medicine (NIH department code)
From the FY2022 NIH awards this investigator leads as contact PI. The department is the award's.
FY2022 NIH rank #42,221
- Early Career
- Mentor
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2018 through FY2022Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2022 award categories
- Internal Medicine
NIH Funding · FY2022
Linked Award Amount
$136.7K
Full award amounts, FY2022
Award Records
1
Records listing this PI
Award-Linked Rank
#42,221
By linked amount among FY2022 PIs
Earliest Year Loaded
2018
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2022 award records by amount
NIH award records listing Ganesan, Murali as a PI. Multi-PI records show the full award amount for context.
- 5K01AA026864-05K01Contact PIEthanol suppresses HBV peptide-MHC Class I presentation on hepatocytesUniversity of Nebraska Medical Center · Internal Medicine (NIH department code)$136.7Kaward amount
Award organization
Organizations that administered FY2022 awards listing Ganesan, Murali as a PI.
FY2022 award administered by University of Nebraska Medical Center (NE).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2018First NIH AwardUniversity of Nebraska Medical Center
- 2022$500K Cumulative Funding